Karuna Therapeutics Inc (NASDAQ:KRTX)

Delayed Data
As of Feb 06
 +0.16 / +0.08%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Karuna Therapeutics Inc have a median target of 285.00, with a high estimate of 330.00 and a low estimate of 209.00. The median estimate represents a +48.25% increase from the last price of 192.24.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Buy stock in Karuna Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.88%
Growthannually -77.51%


Growthquarterly -91.18%
Growthannually -87.08%
Key to the earnings and sales forecast charts.